208 related articles for article (PubMed ID: 37818076)
1. Investigating novel biomarkers in uterine corpus endometrial carcinoma: in silico analysis and clinical specimens validation via RT-qPCR and immunohistochemistry.
Li J; Ramzan F; Zhong G
Am J Cancer Res; 2023; 13(9):4376-4400. PubMed ID: 37818076
[TBL] [Abstract][Full Text] [Related]
2. Integrated multiplex network based approach reveled CC and CXC chemokines associated key biomarkers in colon adenocarcinoma patients.
Huang W; Hu Y; Zhang X; Xu Y; Sun Z; Ding P; Qian X; Ali A; Chen Z
Am J Cancer Res; 2023; 13(11):5531-5548. PubMed ID: 38058831
[TBL] [Abstract][Full Text] [Related]
3. Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).
Li K; Li D; Hafez B; Bekhit MMS; Jardan YAB; Alanazi FK; Taha EI; Auda SH; Ramzan F; Jamil M
Oncol Res; 2024; 32(4):737-752. PubMed ID: 38560573
[TBL] [Abstract][Full Text] [Related]
4. CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
Wang G; Fu J; Liu M; Zheng Q
PLoS One; 2024; 19(1):e0277872. PubMed ID: 38232115
[TBL] [Abstract][Full Text] [Related]
5. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
Sun X; Chen Q; Zhang L; Chen J; Zhang X
Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
[TBL] [Abstract][Full Text] [Related]
6. CXCL9 correlates with antitumor immunity and is predictive of a favorable prognosis in uterine corpus endometrial carcinoma.
Xue S; Su XM; Ke LN; Huang YG
Front Oncol; 2023; 13():1077780. PubMed ID: 36845675
[TBL] [Abstract][Full Text] [Related]
7. Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation.
Yuan Y; Chen Z; Cai X; He S; Li D; Zhao W
Front Oncol; 2021; 11():766947. PubMed ID: 34868993
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel key genes associated with uterine corpus endometrial carcinoma progression and prognosis.
Li H; Zhou Q; Wu Z; Lu X
Ann Transl Med; 2023 Jan; 11(2):100. PubMed ID: 36819577
[TBL] [Abstract][Full Text] [Related]
9. KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma.
He K; Li J; Huang X; Zhao W; Wang K; Wang T; Chen J; Wang Z; Yi J; Zhao S; Zhao L
Front Oncol; 2023; 13():1090779. PubMed ID: 36776306
[TBL] [Abstract][Full Text] [Related]
10. Deciphering DNA repair gene mutational landscape in uterine corpus endometrial carcinoma patients using next generation sequencing.
Lou J; Chu X; Yang X; Jamil M; Zhu H
Am J Cancer Res; 2024; 14(1):210-226. PubMed ID: 38323278
[TBL] [Abstract][Full Text] [Related]
11. Construction and verification of an endoplasmic reticulum stress-related prognostic model for endometrial cancer based on WGCNA and machine learning algorithms.
Lin S; Wei C; Wei Y; Fan J
Front Oncol; 2024; 14():1362891. PubMed ID: 38725627
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of oxeiptosis-associated lncRNAs and prognosis-related signature genes to predict the immune status in uterine corpus endometrial carcinoma.
Niu L; Wu Z
Aging (Albany NY); 2023 May; 15(10):4236-4252. PubMed ID: 37211398
[TBL] [Abstract][Full Text] [Related]
13. Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma.
Xie BF; Xia Y; Lin DH; Lian B; Zhang ML; Liu L; Qin CR
Comput Intell Neurosci; 2022; 2022():6530884. PubMed ID: 36199963
[TBL] [Abstract][Full Text] [Related]
14. The discovery of promising candidate biomarkers in kidney renal clear cell carcinoma: evidence from the in-depth analysis of high-throughput data.
Li X; Li M; Zhao T; Zhang J
Am J Cancer Res; 2023; 13(9):4288-4304. PubMed ID: 37818073
[TBL] [Abstract][Full Text] [Related]
15. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
[TBL] [Abstract][Full Text] [Related]
16. A novel cuproptosis-related gene signature for overall survival prediction in uterine corpus endometrial carcinoma (UCEC).
Lin S; Xu Y; Liu B; Zheng L; Cao C; Wu P; Ding W; Ren F
Heliyon; 2023 Apr; 9(4):e14613. PubMed ID: 37035374
[TBL] [Abstract][Full Text] [Related]
17. Characterization and verification of MMP family members as potential biomarkers in kidney clear cell renal carcinoma.
Zhao T; Li X; Li M; Jamil M; Zhang J
Am J Cancer Res; 2023; 13(9):3941-3962. PubMed ID: 37818055
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive bioinformatic analyses of lncRNA-mediated ceRNA network for uterine corpus endometrial carcinoma.
Cai Y; Cui J; Wang Z; Wu H
Transl Cancer Res; 2022 Jul; 11(7):1994-2012. PubMed ID: 35966302
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma.
Huang J; Chen Z; Ding C; Lin S; Wan D; Ren K
Front Oncol; 2021; 11():711402. PubMed ID: 34497764
[TBL] [Abstract][Full Text] [Related]
20. Screening and validation of potential markers associated with uterine corpus endometrial carcinoma and polycystic ovary syndrome based on bioinformatics methods.
Wu R; Wu C; Zhu B; Li J; Zhao W
Front Mol Biosci; 2023; 10():1192313. PubMed ID: 37363398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
